Health
Novavax Inks Vaccine Deals In Japan, India; Analyst Sees 70% Stock Upside – Gooruf
As part of the partnership, Novavax ( NVAX ) will license COVID-19 vaccine technology to Takeda for local production and commercialization in Japan. In exchange, Novavax will receive payments based on the achievement of certain development and commercial mile…
Article summary
As part of the partnership, Novavax ( NVAX ) will license COVID-19 vaccine technology to Takeda for local production and commercialization in Japan. In exchange, Novavax will receive payments based on the achievement of certain development and commercial milestones, as well as a portion of vaccine proceeds….
-
Noosa News21 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News22 hours agoYoung voices shape Sunshine Coast’s future
-
Business21 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News19 hours agoCopperString transmission line projected to cost almost $14b amid massive blowout